Serum level of prophylactic antibiotics in cardiac surgery and its implication on surgical site infection (SSI)
- PMID: 36147785
- PMCID: PMC9490157
Serum level of prophylactic antibiotics in cardiac surgery and its implication on surgical site infection (SSI)
Abstract
Background: Surgical site infection in cardiac surgery is still common despite applying preoperative antibiotic prophylaxis as per guidelines. Therefore, the aim of our study was to assess the relationship between perioperative antibiotics serum levels and the incidence of surgical site infection.
Methods: This is a prospective study that included all adult patients who underwent elective coronary artery bypass grafting between June and December 2018. The serum antibiotics levels were measured at 4 different time points. The patients were divided into two groups: The group who developed surgical site infection and the group who did not develop surgical site infection. The serum antibiotics levels were compared between the two groups.
Results: Eighty-seven consecutive patients were enrolled in the study. The overall rate of infection was 17.95% (14/78 patients). High pre-operative HbA1C levels were associated with a higher rate of SSI (SSI 8.46 ± 2.23 vs no SSI 7.28 ± 1.82, P = 0.04). Patients who developed surgical site infection had longer intervals between administration of prophylactic antibiotics and different parts of the procedure than those who did not develop infection T2 (SSI 3.09 ± 1.12 vs no SSI 2.32 ± 0.98, P = 0.004), T3 (SSI 5.74 ± 1.69 vs no SSI 4.68 ± 1.83, P = 0.024) and T4 (SSI 7.35 ± 1.97 vs no SSI 6.01 ± 2.11, P = 0.015).
Conclusion: Prolonging different parts of cardiac surgery procedures could lead to higher risk of infection and better timing of intra-operative re-dosing of prophylactic antibiotics could be guided by measuring intra-operative serum concentrations of these antibiotics.
Keywords: Coronary artery bypass grafting; cefuroxime; prophylactic antibiotics; serum antibiotic concentration; surgical site infection.
AJCD Copyright © 2022.
Conflict of interest statement
None.
Similar articles
-
Evaluating the use of antibiotic prophylaxis during open reduction and internal fixation surgery in patients at low risk of surgical site infection.Injury. 2015 Feb;46(2):184-8. doi: 10.1016/j.injury.2014.07.026. Epub 2014 Aug 7. Injury. 2015. PMID: 25152430
-
The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures.Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Sep 1;38(2):85-97. doi: 10.1515/prilozi-2017-0026. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017. PMID: 28991759 Clinical Trial.
-
The effectiveness of i.v. cefuroxime prophylaxis of surgical site infection after elective inguinal hernia repair with mesh: A retrospective observational study.Eur J Clin Pharmacol. 2016 Sep;72(9):1033-9. doi: 10.1007/s00228-016-2067-4. Epub 2016 May 10. Eur J Clin Pharmacol. 2016. PMID: 27165663
-
Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.Surg Infect (Larchmt). 2019 Sep;20(6):439-443. doi: 10.1089/sur.2019.039. Epub 2019 May 21. Surg Infect (Larchmt). 2019. PMID: 31112072 Review.
-
A Comparative Analysis of Prophylactic Antibiotic Administration in Emergency Surgery Versus Elective Surgery: A Comprehensive Review.Cureus. 2024 Mar 31;16(3):e57338. doi: 10.7759/cureus.57338. eCollection 2024 Mar. Cureus. 2024. PMID: 38690454 Free PMC article. Review.
Cited by
-
Effective Antimicrobial Prophylaxis in Surgery: The Relevance and Role of Pharmacokinetics-Pharmacodynamics.Antibiotics (Basel). 2023 Dec 14;12(12):1738. doi: 10.3390/antibiotics12121738. Antibiotics (Basel). 2023. PMID: 38136772 Free PMC article. Review.
References
-
- Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA. 2006;296:2460–6. - PubMed
-
- Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, Jacobs M, Fernando H, Bridges C Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg. 2007;83:1569–76. - PubMed
-
- Savino JA, Smeland J, Flink EL, Ruperto A, Hines A, Sullivan T, Galvin K, Risucci DA. Implementation of an evidence-based protocol for surgical infection prophylaxis. Advances in patient safety: from research to implementation (Volume 3: Implementation Issues) Rockville (MD): Agency for Healthcare Research and Quality (US); 2005. - PubMed
-
- Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000;118:397–402. - PubMed
-
- Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg. 2006;81:397–404. - PubMed
LinkOut - more resources
Full Text Sources